Vanguard Group’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.17M | Buy |
139,699
+4,284
| +3% | +$43.2K | ﹤0.01% | 3734 |
|
|
2025
Q3 | $1.62M | Buy |
135,415
+14,874
| +12% | +$182K | ﹤0.01% | 3641 |
|
|
2025
Q2 | $1.02M | Hold |
120,541
| – | – | ﹤0.01% | 3738 |
|
|
2025
Q1 | $1.36M | Buy |
120,541
+150
| +0.1% | +$2.72K | ﹤0.01% | 3614 |
|
|
2024
Q4 | $2.46M | Hold |
120,391
| – | – | ﹤0.01% | 3497 |
|
|
2024
Q3 | $4.78M | Buy |
120,391
+8,563
| +8% | +$230K | ﹤0.01% | 3287 |
|
|
2024
Q2 | $1.97M | Hold |
111,828
| – | – | ﹤0.01% | 3554 |
|
|
2024
Q1 | $1.86M | Buy |
111,828
+4,330
| +4% | +$63K | ﹤0.01% | 3617 |
|
|
2023
Q4 | $2.03M | Buy |
107,498
+69,816
| +185% | +$1.31M | ﹤0.01% | 3596 |
|
|
2023
Q3 | $784K | Buy |
37,682
+13,290
| +54% | +$404K | ﹤0.01% | 3918 |
|
|
2023
Q2 | $1.33M | Buy |
24,392
+2,210
| +10% | +$68K | ﹤0.01% | 3808 |
|
|
2023
Q1 | $401K | Hold |
22,182
| – | – | ﹤0.01% | 4181 |
|
|
2022
Q4 | $225K | Buy |
22,182
+16
| +0.1% | +$171 | ﹤0.01% | 4290 |
|
|
2022
Q3 | $293K | Sell |
22,166
-4,683
| -17% | -$70.9K | ﹤0.01% | 4350 |
|
|
2022
Q2 | $346K | Hold |
26,849
| – | – | ﹤0.01% | 4371 |
|
|
2022
Q1 | $1.39M | Sell |
26,849
-4,892
| -15% | -$207K | ﹤0.01% | 4108 |
|
|
2021
Q4 | $1.43M | Sell |
31,741
-547
| -2% | -$29.3K | ﹤0.01% | 4157 |
|
|
2021
Q3 | $2.12M | Sell |
32,288
-603
| -2% | -$45.7K | ﹤0.01% | 4041 |
|
|
2021
Q2 | $3.29M | Sell |
32,891
-50
| -0.2% | -$5.16K | ﹤0.01% | 3800 |
|
|
2021
Q1 | $4.2M | Buy |
32,941
+7,591
| +30% | +$1.12M | ﹤0.01% | 3619 |
|
|
2020
Q4 | $2.82M | Buy |
25,350
+1,429
| +6% | +$160K | ﹤0.01% | 3569 |
|
|
2020
Q3 | $2.81M | Sell |
23,921
-4,770
| -17% | -$825K | ﹤0.01% | 3386 |
|
|
2020
Q2 | $6.15M | Buy |
28,691
+993
| +4% | +$235K | ﹤0.01% | 3006 |
|
|
2020
Q1 | $6.25M | Buy |
27,698
+2,546
| +10% | +$726K | ﹤0.01% | 2854 |
|
|
2019
Q4 | $6.75M | Sell |
25,152
-1,295
| -5% | -$326K | ﹤0.01% | 3053 |
|
|
2019
Q3 | $8.03M | Buy |
26,447
+508
| +2% | +$156K | ﹤0.01% | 2927 |
|
|
2019
Q2 | $8.59M | Buy |
25,939
+5,501
| +27% | +$2.79M | ﹤0.01% | 2949 |
|
|
2019
Q1 | $12.8M | Buy |
20,438
+5,627
| +38% | +$2.57M | ﹤0.01% | 2695 |
|
|
2018
Q4 | $3.68M | Sell |
14,811
-6,439
| -30% | -$2.56M | ﹤0.01% | 3192 |
|
|
2018
Q3 | $9.86M | Sell |
21,250
-20
| -0.1% | -$9.69K | ﹤0.01% | 2927 |
|
|
2018
Q2 | $11.5M | Buy |
21,270
+626
| +3% | +$375K | ﹤0.01% | 2832 |
|
|
2018
Q1 | $11.8M | Buy |
20,644
+166
| +0.8% | +$105K | ﹤0.01% | 2748 |
|
|
2017
Q4 | $13.1M | Buy |
20,478
+755
| +4% | +$532K | ﹤0.01% | 2698 |
|
|
2017
Q3 | $18.6M | Buy |
19,723
+806
| +4% | +$617K | ﹤0.01% | 2520 |
|
|
2017
Q2 | $16.5M | Buy |
18,917
+826
| +5% | +$677K | ﹤0.01% | 2541 |
|
|
2017
Q1 | $12.5M | Buy |
18,091
+850
| +5% | +$560K | ﹤0.01% | 2664 |
|
|
2016
Q4 | $12.4M | Buy |
17,241
+277
| +2% | +$191K | ﹤0.01% | 2646 |
|
|
2016
Q3 | $12.5M | Buy |
16,964
+308
| +2% | +$249K | ﹤0.01% | 2581 |
|
|
2016
Q2 | $13.9M | Buy |
16,656
+759
| +5% | +$706K | ﹤0.01% | 2492 |
|
|
2016
Q1 | $13.1M | Buy |
15,897
+774
| +5% | +$608K | ﹤0.01% | 2471 |
|
|
2015
Q4 | $17M | Buy |
15,123
+458
| +3% | +$533K | ﹤0.01% | 2369 |
|
|
2015
Q3 | $12.4M | Buy |
14,665
+799
| +6% | +$1.16M | ﹤0.01% | 2490 |
|
|
2015
Q2 | $24.6M | Buy |
13,866
+422
| +3% | +$536K | ﹤0.01% | 2262 |
|
|
2015
Q1 | $16.2M | Buy |
13,444
+1,348
| +11% | +$1.58M | ﹤0.01% | 2415 |
|
|
2014
Q4 | $13.7M | Buy |
12,096
+2,681
| +28% | +$2.75M | ﹤0.01% | 2408 |
|
|
2014
Q3 | $9.47M | Buy |
9,415
+459
| +5% | +$519K | ﹤0.01% | 2522 |
|
|
2014
Q2 | $11.8M | Buy |
8,956
+114
| +1% | +$137K | ﹤0.01% | 2434 |
|
|
2014
Q1 | $12.3M | Buy |
8,842
+1,162
| +15% | +$1.51M | ﹤0.01% | 2390 |
|
|
2013
Q4 | $8.82M | Buy |
7,680
+759
| +11% | +$1.05M | ﹤0.01% | 2521 |
|
|
2013
Q3 | $8.69M | Buy |
6,921
+335
| +5% | +$227K | ﹤0.01% | 2464 |
|
|
2013
Q2 | $2.62M | Buy |
+6,586
| New | +$2.79M | ﹤0.01% | 2973 |
|
Other funds holding RMTI
PCM
Vanguard Group's RMTI Position: Q4 2025 in Review
Vanguard Group increased its Rockwell Medical (RMTI) stake by 3.2% in Q4 2025, buying an estimated $43.2K and bringing the position to 139,699 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3734.
Vanguard Group first reported a position in RMTI in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.6M in Q2 2015. 36 funds tracked by Wall St. Rank hold RMTI as of Q4 2025.
- Vanguard Group held 139,699 shares of Rockwell Medical worth $1.17M as of Q4 2025.
- Vanguard Group bought 4,284 Rockwell Medical shares in Q4 2025, an estimated $43.2K.
- Rockwell Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3734 holding.
- Vanguard Group first reported a position in Rockwell Medical in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Rockwell Medical position peaked at $24.6M in Q2 2015.
- 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.